ĀÜĄņĀŅĀ×

Gary Zammit, is the President & CEO of Clinilabs Drug Development Corporation, a full-service CRO that provides clinical drug development to industry, focusing on CNS therapeutics. Gary Zammit is a scientist and former academician who founded Clinilabs Drug Development Corporation in 2001, having the belief that there was an industry need for a specialty CNS CRO that could improve the way new drugs and medical devices are developed. Dr. Zammit is widely sought for his expertise in neuropsychiatric drug development. Gary has authored more than 230 original publications and 2 books, and has served as a reviewer and editor for well-known medical journals. He is committed to ensuring that Clinilabs Drug Development Corporationā€™s senior management remains involved in every project that they accept, so that clients have easy and immediate access to the leadership of a high-performance development team.